The investigators compare the primary and secondary outcome measures using accelerated intermittent theta burst stimulation (aiTBS, 20 sessions active and 20 sessions sham in a counterbalanced crossover design) to treat depressive symptoms with 2 parallel arms of intervention: personalized (stimulation position based on participants' brain networks) vs conventional (stimulation in F3 position of the 10-20 EEG cap) aiTBS.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
92
Accelerated intermittent theta burst stimulation (aiTBS, 4 sessions per day with at least 20 minutes pause between sessions) in the left dorsolateral prefrontal cortex (DLPFC)
Laboratory of Systems Neuroscience and Imaging in Psychiatry (SNIP-Lab Göttingen)
Göttingen, Germany
Montgomery-Åsberg Depression Rating Scale (MADRS scores in units of scale)
Administer Rating Scale
Time frame: 6 weeks
heart rate and its variability in RR slope and RMSSD values
Potential marker of treatment response
Time frame: 4-6 weeks
Hamilton Rating Scale for Depression (HAMD-17 scores in units of scale)
Administer Rating Scale
Time frame: 6 weeks
Beck Depression Inventory (BDI-2 scores in units of scale)
Self Rating Scale
Time frame: 6 weeks
DMN decoupling / other networks in rho and z values
Potential markers of treatment response
Time frame: 4-6 weeks
epi / genetic markers of neuroplasticity in ng
Potential markers of treatment response
Time frame: 5-6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.